Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Nov 04, 2017 11:41am
77 Views
Post# 26905837

RE:RE:RE:$100 million...

RE:RE:RE:$100 million...
skier59 wrote: We don't need $100 million upfront. Look at how that deal was done with Frost and that Pharma company in Japan. Small up front payment of $5-10 million is all we need right now, and then once certain milestones are achieved such as Phase 2 approval, which is really a slam dunk for us, there would be another injection of cash and then an upfront payment for Licensing on commercialization. The deal could be announced as a $100 million deal and the market will jump in very quickly. It will demonstrate a conviction from a very well respected businessman in the USA. Not 1 new share issued in the market, Johnny BJ loses his job here, and goes and works on another board with a new avatar. Peace and Love :) 

Bada Bing, Bada Bang, Kaboom....$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$


That is a great idea ,as 5 -10 M to Dr.Frost is only pocket change, ask for the help like that in exchange of Dr. Forest's own holding on Tlt not being diluted by shameless low PP. I think Frost would love to do that, and in fact it's a win-win for both sides, Tlt could get to money of development and Opko 's holding won't get diluted by 3rd party ' low PP. They can negotiate a better deal just with the prerequisite of no further PP needed any more from any side( especially from basement boys 'side). I think all the long shareholders would love to see that happens soon. All in all, RW should know, no useless PP is needed. There are hundreds of better solutions, far more better than engaged with the former rapers to do stupid low valued PP by giving out 25% of the valuable future of company 's holding for nothing.
Bullboard Posts